As described in (29), at the end of the 55-day study following 30mg/kg BW EHop-016, administered 3X a week by IP, to nude mice bearing GFP-HER2-BM mammary tumors, the plasma and tumors were extracted and subjected to cytokine arrays. Here, ERBB2 is linked to breast cancer.